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1568Objectives: Extracardiac conduits are widely used to complete a Fontan circulation in patients with
univentricular hearts. Although polytetrafluoroethylene conduits have proven good long-term patency, Dacron
(polyethylene terephthalate) prostheses are still infrequently applied, with, as yet, no information on the
long-term patency.
Methods: All patients who received an extracardiac Dacron conduit (n ¼ 12) were retrospectively studied. The
initial conduit size was 16 mm in all recipients. The mean age at Fontan completion was 3.1 0.7 years. Patients
with clinical symptoms and/or significant conduit stenosis (>50% of diameter) underwent reoperation.
Results:Of the 12 patients, 8 underwent reoperation (75%) at a mean interval of 6.5 1.8 years after the Fontan
operation. All conduits were replaced by an 18-mm polytetrafluoroethylene graft. The explants showed
ubiquitous tissue deposits on the inner surface, with a residual internal diameter from 8 to 11 mm. All patients
survived the extracardiac conduit replacement. Recovery was uneventful, except that 1 patient experienced
long-lasting pleural fluid drainage. The mean hospital stay was 10.6  12.0 days.
Conclusions: The incidence of extracardiac Dacron conduit stenosis in total cavopulmonary connection patients
is high. These data indicate that the use of this type of conduit should be avoided. Vigilant follow-up is
advised for those patients who have undergone Fontan completion with a Dacron extracardiac conduit. (J Thorac
Cardiovasc Surg 2014;147:1568-72)The Fontan operation, as a staged procedure for patients
born with a univentricular heart, has been successfully
modified during the previous years.1,2 One of the
alternatives to direct systemic venous blood flow from the
inferior caval vein to the pulmonary artery is the use of an
extracardiac conduit. This conduit has been preferred by
many surgeons because of the superior hemodynamics
and few postoperative complications.3 The long-term
adequacy of the extracardiac conduit cross-sectional area,
however, has been a subject of continuous attention.4,5
The growth of the child and stenosis of the tube graft has
been feared to cause compromised inferior caval vein
drainage, significant enough to cause a mismatch to body
surface area.6
Studies addressing the occurrence of extracardiac total
cavopulmonary connection (TCPC) conduit stenosis and
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The Journal of Thoracic and Cardiovascular Surmost surgeons adhere to polytetrafluoroethylene (PFTE;
GORE-TEX, WL Gore & Associates, Newark, Del) to
accomplish the TCPC, polyethylene terephthalate (Dacron;
DuPont, Wilmington, Del) is still infrequently used as an
alternative graft material for this indication.2,7,8 The
preference for PTFE vascular grafts might have been
based on a few early reports of Dacron conduit stenosis
and on the more favorable material characteristics of
PTFE (less contact activation and less compliance
mismatch of PTFE compared with Dacron).9 Moreover,
the mid- and long-term outcomes with extracardiac PTFE
in Fontan patients have shown excellent results without
stenosis at a mean follow-up of 5 and 8 years, respec-
tively.10,11 In contrast, the long-term follow-up of Dacron
conduits has not yet been reported. From 2002 to 2003, a
limited number of Dacron extracardiac conduits were
implanted in our center by our precedent colleagues. The
present study reports our long-term follow-up experience
with this type of extracardiac conduit for TCPC.
METHODS
Patient Characteristics
From January 2002 to June 2003, a Dacron tube graft was temporarily
used by our former staff for extracardiac Fontan completion in a cohort of
14 patients at the Wilhelmina Children’s Hospital, University Medical
Center Utrecht (Utrecht, The Netherlands). Since 2004, PTFE conduits
have been exclusively used by us for this indication. In 13 patients, a
gelatin-impregnated knitted Dacron graft (Vascutek, Scotland, United
Kingdom) was used, and in 1 patient, a collagen-impregnated Dacron
prosthesis (Hemashield; Meadox Medical, Oakland, NJ) was used.gery c May 2014
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PLE ¼ protein-losing enteropathy
PFTE ¼ polytetrafluoroethylene
TCPC ¼ total cavopulmonary connection
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ranged from 2.4 to 4.5 years (mean, 3.1  0.7). Fontan completion was
performed with cardiopulmonary bypass and a beating heart throughout
the whole procedure. All patients received anticoagulants after the
operation. These started after extubation with acenocoumarol to achieve
an international normalized ratio of 2.0 to 3.0. Because of minor
bleeding complications, 2 patients were switched to antiplatelet therapy
(acetylsalicylic acid) 5 and 8 months postoperatively.
Follow-up
One patient died early after the operation in cardiac failure, and one
patient was lost to follow-up 4.9 years after the Fontan procedure.
Therefore, the study group consisted of 12 patients, with a mean follow-
up period after the Fontan operation of 9.7  0.8 years (range, 8.6-10.6).
The annual follow-up examination included anamnesis, physical examina-
tion, and, on indication, transthoracic echocardiography. In the case of
clinical or echocardiographic suspicion of conduit stenosis, cardiac
catheterization (n¼ 8) and computed tomography (n¼ 2) were performed
to assess conduit patency, respectively. The patients were scheduled for
reoperation when exercise tolerance was reduced (greater than New York
Heart Association class II), the noninvasively measured peripheral tissue
oxygen saturation was less than 90%, signs of protein-losing enteropathy
(PLE) were present, or in the case of dysrhythmias and/or liver dysfunction.
Patients without clinical symptoms but with at least a 50% conduit
diameter reduction were also scheduled for conduit replacement. One
explanted gelatin-sealed Dacron prosthesis was examined histologically.RESULTS
From August 2007 to November 2012, 8 patients were
diagnosed with extracardiac conduit stenosis requiring
reoperation at a mean interval of 6.5  1.8 years after the
Fontan operation (Table 1). Oral anticoagulants were
continuously used by all patients (acenocoumarol in 6 and
acetylsalicylic acid in 2). Three patients presented withTABLE 1. Data from patients with surgical intervention
Pt. no. Preoperative symptoms Diagnostic tool
Di
st
(
1 Progressive exercise
intolerance
Echocardiography, angiography, CT
2 PLE Echocardiography, angiography
3 Progressive exercise
intolerance
Echocardiography, angiography
4 Progressive exercise
intolerance
Echocardiography, angiography
5 None Echocardiography, angiography
6 None Echocardiography, angiography
7 None Echocardiography, angiography
8 None Echocardiography, angiography, CT
Pt. no., Patient number; TCPC, total cavopulmonary connection; IVC, inferior vena cava;
The Journal of Thoracic and Cardecreased exercise tolerance, and 1 patient had PLE. In
these 4 symptomatic patients, significant conduit stenosis
was diagnosed by angiography (Figure 1). With regard to
this high incidence of stenosis, a database search was
done to identify all patients with this type of conduit. In
all identified patients, conduit patency was assessed
using transthoracic echocardiography. Angiography and
computed tomography could establish the suspected
diagnosis of conduit stenosis of more than 50% in 3
asymptomatic patients. The eighth patient presented with
left pulmonary artery stenosis, dysrhythmias and conduit
narrowing of 40%. After interventional left pulmonary
artery stent placement, he underwent epicardial pacemaker
implantation and an extracardiac conduit change
concomitantly.
At the latest follow-up examination, the remaining 4
patients had not had an indication for reoperation at
10.0  0.6 years of follow-up. All were in good clinical
condition with moderate conduit stenosis (10-12 mm)
determined by echocardiography.Reoperation
The patient weight and length at reoperation was 30 11
kg and 134  18 cm, respectively. The procedure was
performed on the beating heart with a standard cardio-
pulmonary bypass technique and mild hypothermia
(32C). Femoral vein cannulation was performed in 7
patients; however, in 1 patient (14 kg), the femoral vein
was too small and inferior caval vein cannulation was
performed. In all patients, extracardiac conduits were
replaced by an 18-mm PTFE graft. The mean hospital
stay after revision was 10.6  12.0 days (range, 4-40). All
patients, except for 1, experienced an uneventful post-
operative course. The postoperative recovery for the 1
patient was complicated by persistent pleural effusion. All
preoperative symptomatic patients improved their exercise
tolerance. Two have been able to participate in sportsameter
enosis
mm)
Revision
after
TCPC (yr)
Weight
(kg)
Stenosis
(mm)
Mean IVC
pressure
(mm Hg)
Mean Fontan
pressure
(mm Hg)
8 5.6 24 8 11 11
6 5.2 24 6 14 14
6 5.7 15 6 13 12
10 4.3 20 7 — —
6 5.7 40 8 17 15
8 7.5 41 9 18 17
8 8.5 42 8 16 16
10 9.3 30 10 — —
CT, computed tomography; PLE, protein-losing enteropathy.
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FIGURE 1. Typical angiographic example of a stenosed extracardiac
Dacron conduit. SVC, Superior vena cava; RPA, right pulmonary artery;
LPA, left pulmonary artery; C, conduit; IVC, inferior vena cava.
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leaving only mild hypoproteinemia.Explant Analysis
All explanted conduits showed excessive stenosis by
tissue deposition (on the entire inner surface) over the full
conduit length. The internal explant diameter measured
intraoperatively using a Hegar dilator varied from 8 to
11 mm (Figure 2).
One explanted gelatin-sealed Dacron prosthesis was
examined histologically. The explant was fixed in 4%FIGURE 2. Left, Vascutek graft after explantation with neointima proliferatio
diameter is depicted by the 8-mm Hegar dilator.
1570 The Journal of Thoracic and Cardiovascular Surformalin and embedded in paraffin. Sections of 4 mm
were stained with hematoxylin, eosin, and Sirius red for
evaluation of the collagen depositions and with antibodies
against CD31 to evaluate the presence of an endothelial
lining. The inner lining of the explant consisted of a thick
layer of collagen (Figure 3, A and B) covered with an intact
continuous layer of endothelial cells (Figure 3, C). Some
ingrowth of vessels was present in the intima layer
(Figure 3, C). In the wall of the Dacron prosthesis, collagen
depositions were observed, with an occasional foreign body
giant cell (Figure 3, D).DISCUSSION
A variety of factors, including arrhythmias, atrioventric-
ular valve regurgitation, cyanosis, and ventricular dys-
function, can impair the Fontan circulation and prompt
reintervention.12 A failing Fontan circulation can also be
caused by obstruction of the extracardiac conduit itself.
Since the 1990s, most centers have abandoned collagen-
sealed Dacron conduits because of increasing experience
and reports of graft stenosis.7 However, for gelatin-sealed
grafts, this complication has not yet been reported. The pre-
sent study is the first to report extensive intima hyperplasia
in all explants. The data showed that a gelatin coating does
not prevent Dacron venous conduits from narrowing, as was
probably thought by our former colleagues. With the
current policy introduced in 2004 of using only PTFE
conduits of at least 18 mm in diameter without postopera-
tive anticoagulant treatment except for aspirin, we have
not encountered this particular problem in any of our extrac-
ardiac Fontan patients (n ¼ 85, follow-up, 7.4  1.6 years;
range, 0-10). Therefore, we have attributed this complica-
tion to the nature of the Dacron conduit.
In our cohort, the first 4 reoperations for conduit
narrowing were performed in symptomatic patients withn covering the entire inner surface of the conduit. Right, The graft luminal
gery c May 2014
FIGURE 3. Histologic examination of explanted Dacron conduit. A, Fibrotic neointima, collagen richness of neointima. B, Sirius red vital intact
endothelium, C, CD31 stain, and D, fibrosis between the Dacron.
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Angiography, however, could only detect a mean gradient
of 1 mmHg between the inferior vena cava and extracardiac
conduit in 2 patients and of 2 mm Hg in 1 patient. Also, all
other patients showed no gradient, with a mean pressure of
the Fontan circulation of 11 to 17 mm Hg. Despite the
discrepancy between the clinical symptoms and verifiable
hemodynamic relevance, angiography has remained our
preferred diagnostic tool. Exclusion of many other possible
reasons for failing Fontan can be best accomplished with
this technique. With increased experience and the
observation that conduit replacement can be performed
safely and successfully, we have extended the indication
for reoperation to asymptomatic patients with only a
significant conduit narrowing (>50%). Patients with
moderate (<50%) narrowing remain under vigilant obser-
vation, because reoperation in these patients is expected
to be unavoidable at or before adolescence. The additional
growth of these patients to at least 20 to 25 kg is preferred to
facilitate easy femoral venous cannulation and thereby offer
a safe procedure to these asymptomatic patients.
Little is known about the technical difficulties and risks
of reoperation in patients with an extracardiac conduit
stenosis, because this problem has not been reported in
patients with a PTFE conduit.4,10,11 All adhesions, which
were very dense, especially around the Dacron graft, had
to be totally freed. The risk of damage to the right phrenic
nerve and medially located atrial chamber is substantial.
The risk of damage to the conduit itself, however, is
relatively low, because the inner surface peel of 3 toThe Journal of Thoracic and Car4 mm serves as protection against unintentional bleeding.
We, therefore, have preferred sharp dissection on the
surface of the conduit, instead of dissecting between the
different structures. Once the conduit has been completely
dissected free, a Glover spoon clamp can be placed on the
inferior caval vein–conduit transition. This provides just
enough tissue cuff for the new anastomosis but leaves
little or no space for inferior caval vein cannulation.
Femoral vein cannulation is therefore key for a safe
procedure. In only 1 patient was bicaval cannulation
performed because of a too small femoral vein.
Furthermore, we found a relatively fixed size of the
dissected inferior caval vein owing to the 16-mm primary
implanted Dacron conduit and obvious shrinkage of the
atrial cuff, which restricted us to using an 18-mm conduit.
The main limitation of the present study was that it
remains unclear why the Dacron conduit had been chosen.
The easier handling characteristics of the Dacron graft at
the side of the anastomosis with fewer anastomotic bleeding
sites or the assumption of better flow properties of a gelatin-
coated graft were probably the reasons. Additionally, in all
patients, a 16-mmDacron graft was used, which currently is
considered quite small for patients aged 2 to 4 years. The
contribution of this small size to the development of the
pannus inside the graft also could not be answered, because
we have no experience with the 16-mm PTFE conduit.
CONCLUSIONS
The extracardiac Dacron conduits applied for TCPC in
the Fontan circulation demonstrated a high incidence ofdiovascular Surgery c Volume 147, Number 5 1571
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Dstenosis, requiring replacement. These data indicate that the
use of this type of conduit should be avoided. For patients
who have received a Dacron graft in the past, vigilant
follow-up is advised.
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